PYC Therapeutics | PYC - Operating Profit

Stock Price
1.50
Daily Change
0.01 0.67%
Monthly
-8.81%
Yearly
22.45%
Q1 Forecast
1.47

PYC Therapeutics reported AUD-13.47M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Avita Medical AUD -11.15M 1.19M Jun/2025
Medical Developments International AUD -480K 662K Jun/2025
Neuren Pharmaceuticals AUD 5.45M 171.24M Jun/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025